SEC Form 4 · accession 0001127602-19-003854
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis W Sullivan
Director
Period of report
Feb 1, 2019
Accepted (ET)
Feb 4, 2019 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 1, 2019 | M | 1,000 | $54.77 | A | 2,370 | D | |
| Common Stock | Feb 1, 2019 | D | 1,000 | $115.83 | D | 1,370 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $54.77 | Feb 1, 2019 | M | 1,000 | D | Jun 29, 2012 | Jun 29, 2021 | Common Stock | 1,000 | 9,000 | D |
Explanation of responses
- F1This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.